Kuros Biosciences AG (SWX:KURN)
20.86
+0.16 (0.77%)
May 15, 2026, 2:17 PM CET
Kuros Biosciences AG Employees
Kuros Biosciences AG had 178 employees as of December 31, 2025. The number of employees increased by 56 or 45.90% compared to the previous year.
Employees
178
Change
56
Growth
45.90%
Revenue / Employee
650.66K CHF
Profits / Employee
11.36K CHF
Market Cap
810.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 178 | 56 | 45.90% |
| Jun 30, 2025 | 158 | - | - |
| Dec 31, 2024 | 122 | 42 | 52.50% |
| Dec 31, 2023 | 80 | 14 | 21.21% |
| Dec 31, 2022 | 66 | 8 | 13.79% |
| Dec 31, 2021 | 58 | 12 | 26.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,267 |
| Lonza Group AG | 20,000 |
| Galderma Group AG | 7,676 |
| Aevis Victoria | 4,870 |
| SKAN Group AG | 1,737 |
| PolyPeptide Group AG | 1,440 |
| Medartis Holding AG | 1,337 |
Kuros Biosciences AG News
- 8 days ago - Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth - GlobeNewsWire
- 4 weeks ago - Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026 - GlobeNewsWire
- 2 months ago - Kuros Biosciences AG Earnings Call Transcript: H2 2025 - Transcripts
- 9 months ago - Kuros Biosciences AG Earnings Call Transcript: H1 2025 - Transcripts
- 1 year ago - Kuros Biosciences AG Transcript: CMD 2025 - Transcripts
- 1 year ago - Kuros Biosciences AG Earnings Call Transcript: H2 2024 - Transcripts
- 1 year ago - Kuros Biosciences AG Earnings Call Transcript: H1 2024 - Transcripts
- 2 years ago - Kuros Biosciences AG Earnings Call Transcript: H1 2023 - Transcripts